Cathepsin B expression and localization in glioma progression and invasion.
The poor prognosis of human malignant gliomas is due to their invasion and recurrence, the molecular mechanisms of which remain poorly characterized. We have accumulated substantial evidence implicating the cysteine protease cathepsin B in human glioma malignancy. Increases in cathepsin B expression were observed throughout progression. In primary brain tumor tissue, transcript abundance (Northern blot analysis) increased in low-grade astrocytoma to high-grade glioblastoma from 3- to 6-fold, respectively, above normal brain levels. This increase correlated with increases in protein abundance (from + to ) as measured by immunohistochemistry. Furthermore, in glioblastoma cell lines increases in transcript abundance (ranging from 3- to 12-fold) were accompanied by increases in enzyme activity (44-133 nmol/min x mg protein). Altered subcellular localization was observed both immunohistochemically and by indirect immunofluorescence confocal microscopy and was found to correlate with increased grade. In addition, this increase in cathepsin B expression and altered subcellular localization correlated with histomorphological invasion and clinical evidence of invasion as detected by magnetic resonance imaging. These data support the hypothesis that cathepsin B plays a role in human glioma progression and invasion.
Henry Ford Midwest Neuro-Oncology Center, Henry Ford Hospital, Detroit, Michigan 48202.
S A
SA
Rempel
M L
ML
Rosenblum
T
T
Mikkelsen
P S
PS
Yan
K D
KD
Ellis
W A
WA
Golembieski
M
M
Sameni
J
J
Rozhin
G
G
Ziegler
B F
BF
Sloane
D000818:Animals; D015152:Blotting, Northern; D002401:Cathepsin B / Q000032:analysis* / Q000235:genetics; D005910:Glioma / Q000175:diagnosis / Q000201:enzymology* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D009361:Neoplasm Invasiveness; D011817:Rabbits
D002401:Cathepsin B